Q301--Molecular Residual Disease (MRD) Testing Services Six month extension
Awarded Limited / Sole Source Justification Posted
- Solicitation number
- 36C10G22D0036
- Agency
-
Headquarters
Department of Veterans Affairs
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 36C10G22D0036-36C10G22D0036-P00004
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs (VA) has issued a Limited / Sole Source Justification Notice for a six-month extension of Molecular Residual Disease (MRD) Testing Services, awarded to Natera, Inc. on March 13, 2025. The contract extension, covering the period from March 15, 2025 through September 14, 2025, will provide next-generation sequencing based tests (somatic and germline), immunohistochemistry, microarray, FISH, and other cancer testing methodologies across 130 VA Medical Centers. The justification for this sole source procurement under FAR 6.302-1 is to allow the VA National Precision Oncology Program time to finalize performance requirements and complete market research for a future competitive recompete effort. While the award amount is listed as $0.00, the extension will utilize existing products and pricing previously determined to be fair and reasonable, with no new products or tests to be added during this period. The National Precision Oncology Program has determined that continuing these testing services is advantageous for early cancer cell detection, making this short-term extension a strategic move to maintain critical medical testing capabilities.
Notice text
Minimal Residual Disease Testing (MRDT) Services Six Month Extension Awarded contract 36C10G22D0036 to NATERA, INC. for unknown amount on 2025-03-13.
Files
| File | Type | Posted |
|---|---|---|
| postable JA 36C10G22D0036 P4 Redacted.pdf | ||
| 36C10G22D0036 P00004_1.docx | DOCX document |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Q301--NEW – STX Specialized Molecular Residual Disease Testing | Veterans Integrated Service Network 17 | No set-aside | |
| Q301--FY27 (BASE+4) STAT Laboratory Testing - Syracuse (VA-27-00010334) | Veterans Integrated Service Network 2 | No set-aside | |
| Q301--leptomeningeal and coronary research services. | Veterans Integrated Service Network 22 | No set-aside | |
| J066--Azenta NitroStore System PM and Support Services | Veterans Integrated Service Network 4 | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity